NCT00262353

Brief Summary

Comparison of the efficacy of dialysis by conventional dialysis versus Prometheus artificial hepatic system

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 6, 2005

Completed
Last Updated

July 2, 2021

Status Verified

July 1, 2021

First QC Date

December 4, 2005

Last Update Submit

July 1, 2021

Conditions

Renal Failure, Chronic

Outcome Measures

Primary Outcomes (1)

  • Determination of the concentration of protein-bound toxins after treatment with different artificial devices

Secondary Outcomes (1)

  • Determination of the kinetics of protein-bound toxins after treatment with different artificial devices

Interventions

Dialysis with different artificial devicesDEVICE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stable patients
  • At least 3 months on dialysis
  • Arterio-venous fistula

You may not qualify if:

  • Diabetic patients
  • Malignancies
  • Acute illnesses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Links

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

Dialysis

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Chemistry Techniques, AnalyticalInvestigative TechniquesChemical Phenomena

Study Officials

  • Raymond Vanholder, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2005

First Posted

December 6, 2005

Last Updated

July 2, 2021

Record last verified: 2021-07

Locations

BE(1)